TScan Therapeutics
TCRX
TCRX
80 hedge funds and large institutions have $242M invested in TScan Therapeutics in 2024 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 19 increasing their positions, 14 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
11% less capital invested
Capital invested by funds: $272M → $242M (-$29.9M)
Holders
80
Holding in Top 10
4
Calls
–
Puts
–
Top Buyers
| 1 | +$16.2M | |
| 2 | +$5.5M | |
| 3 | +$4.94M | |
| 4 |
LP
LMR Partners
London,
United Kingdom
|
+$3.89M |
| 5 |
Adage Capital Partners
Boston,
Massachusetts
|
+$2.92M |
Top Sellers
| 1 | -$2.37M | |
| 2 | -$2.13M | |
| 3 | -$1.77M | |
| 4 |
Goldman Sachs
New York
|
-$1.32M |
| 5 |
Citigroup
New York
|
-$635K |